 | • レポートコード：QYR9ST03165 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、がん腫瘍プロファイリングの世界市場について調査・分析し、がん腫瘍プロファイリングの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（次世代シーケンス（NGS）、ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、in situハイブリダイゼーション（ISH）、マイクロアレイ、その他）、用途別（個別化医療、診断、バイオマーカー発見、予後、研究用）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のがん腫瘍プロファイリング市場動向 ・主要企業別マーケットシェア ・がん腫瘍プロファイリングの種類別市場規模2014-2019 （次世代シーケンス（NGS）、ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、in situハイブリダイゼーション（ISH）、マイクロアレイ、その他） ・がん腫瘍プロファイリングの用途別市場規模2014-2019 （個別化医療、診断、バイオマーカー発見、予後、研究用） ・がん腫瘍プロファイリングの北米市場：主要企業・種類別/用途別市場規模 ・がん腫瘍プロファイリングのヨーロッパ市場：主要企業・種類別/用途別市場規模 ・がん腫瘍プロファイリングの中国市場：主要企業・種類別/用途別市場規模 ・がん腫瘍プロファイリングの日本国内市場：主要企業・種類別/用途別市場規模 ・がん腫瘍プロファイリングの東南アジア市場：主要企業・種類別/用途別市場規模 ・がん腫瘍プロファイリングのインド市場：主要企業・種類別/用途別市場規模 ・がん腫瘍プロファイリングの中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Qiagen N.V.、Roche Molecular Systems Inc.、Abott Molecular、Illumina Inc.、NeoGenomics Laboratories、HTG Molecular Diagnostic、Genomic Health Inc.、Hologic Gen-Probe、BD Biosciences、Siemens Healthineers、Claris Life Sciences、Personal Genome Diagnostics, Inc.、Perthera, Inc.、Foundation Medicine, Inc、V., Strand、ApoCell、Contextual Genomics、Agendia、GenScript） ・がん腫瘍プロファイリングの市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.
In 2018, the global Cancer Tumor Profiling market size was 30200 million US$ and it is expected to reach 115600 million US$ by the end of 2025, with a CAGR of 18.2% during 2019-2025.
This report focuses on the global Cancer Tumor Profiling status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Tumor Profiling development in United States, Europe and China.
The key players covered in this study
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
Market segment by Type, the product can be split into
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Market segment by Application, split into
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Tumor Profiling status, future forecast, growth opportunity, key market and key players.
To present the Cancer Tumor Profiling development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cancer Tumor Profiling are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Tumor Profiling Market Size Growth Rate by Type (2014-2025)
1.4.2 Next-generation Sequencing (NGS)
1.4.3 Polymerase Chain Reaction (PCR)
1.4.4 Immunohistochemistry (IHC)
1.4.5 In Situ Hybridization (ISH)
1.4.6 Microarray
1.4.7 Others
1.5 Market by Application
1.5.1 Global Cancer Tumor Profiling Market Share by Application (2014-2025)
1.5.2 Personalized Medicine
1.5.3 Diagnostics
1.5.4 Biomarker Discovery
1.5.5 Prognostics
1.5.6 Research Applications
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Tumor Profiling Market Size
2.2 Cancer Tumor Profiling Growth Trends by Regions
2.2.1 Cancer Tumor Profiling Market Size by Regions (2014-2025)
2.2.2 Cancer Tumor Profiling Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Cancer Tumor Profiling Market Size by Manufacturers
3.1.1 Global Cancer Tumor Profiling Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Tumor Profiling Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Tumor Profiling Key Players Head office and Area Served
3.3 Key Players Cancer Tumor Profiling Product/Solution/Service
3.4 Date of Enter into Cancer Tumor Profiling Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Tumor Profiling Market Size by Type (2014-2019)
4.2 Global Cancer Tumor Profiling Market Size by Application (2014-2019)
5 United States
5.1 United States Cancer Tumor Profiling Market Size (2014-2019)
5.2 Cancer Tumor Profiling Key Players in United States
5.3 United States Cancer Tumor Profiling Market Size by Type
5.4 United States Cancer Tumor Profiling Market Size by Application
6 Europe
6.1 Europe Cancer Tumor Profiling Market Size (2014-2019)
6.2 Cancer Tumor Profiling Key Players in Europe
6.3 Europe Cancer Tumor Profiling Market Size by Type
6.4 Europe Cancer Tumor Profiling Market Size by Application
7 China
7.1 China Cancer Tumor Profiling Market Size (2014-2019)
7.2 Cancer Tumor Profiling Key Players in China
7.3 China Cancer Tumor Profiling Market Size by Type
7.4 China Cancer Tumor Profiling Market Size by Application
8 Japan
8.1 Japan Cancer Tumor Profiling Market Size (2014-2019)
8.2 Cancer Tumor Profiling Key Players in Japan
8.3 Japan Cancer Tumor Profiling Market Size by Type
8.4 Japan Cancer Tumor Profiling Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Tumor Profiling Market Size (2014-2019)
9.2 Cancer Tumor Profiling Key Players in Southeast Asia
9.3 Southeast Asia Cancer Tumor Profiling Market Size by Type
9.4 Southeast Asia Cancer Tumor Profiling Market Size by Application
10 India
10.1 India Cancer Tumor Profiling Market Size (2014-2019)
10.2 Cancer Tumor Profiling Key Players in India
10.3 India Cancer Tumor Profiling Market Size by Type
10.4 India Cancer Tumor Profiling Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Tumor Profiling Market Size (2014-2019)
11.2 Cancer Tumor Profiling Key Players in Central & South America
11.3 Central & South America Cancer Tumor Profiling Market Size by Type
11.4 Central & South America Cancer Tumor Profiling Market Size by Application
12 International Players Profiles
12.1 Qiagen N.V.
12.1.1 Qiagen N.V. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Tumor Profiling Introduction
12.1.4 Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2014-2019)
12.1.5 Qiagen N.V. Recent Development
12.2 Roche Molecular Systems Inc.
12.2.1 Roche Molecular Systems Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Tumor Profiling Introduction
12.2.4 Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2014-2019)
12.2.5 Roche Molecular Systems Inc. Recent Development
12.3 Abott Molecular
12.3.1 Abott Molecular Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Tumor Profiling Introduction
12.3.4 Abott Molecular Revenue in Cancer Tumor Profiling Business (2014-2019)
12.3.5 Abott Molecular Recent Development
12.4 Illumina Inc.
12.4.1 Illumina Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Tumor Profiling Introduction
12.4.4 Illumina Inc. Revenue in Cancer Tumor Profiling Business (2014-2019)
12.4.5 Illumina Inc. Recent Development
12.5 NeoGenomics Laboratories
12.5.1 NeoGenomics Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Tumor Profiling Introduction
12.5.4 NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2014-2019)
12.5.5 NeoGenomics Laboratories Recent Development
12.6 HTG Molecular Diagnostic
12.6.1 HTG Molecular Diagnostic Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Tumor Profiling Introduction
12.6.4 HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2014-2019)
12.6.5 HTG Molecular Diagnostic Recent Development
12.7 Genomic Health Inc.
12.7.1 Genomic Health Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Tumor Profiling Introduction
12.7.4 Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2014-2019)
12.7.5 Genomic Health Inc. Recent Development
12.8 Hologic Gen-Probe
12.8.1 Hologic Gen-Probe Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Tumor Profiling Introduction
12.8.4 Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2014-2019)
12.8.5 Hologic Gen-Probe Recent Development
12.9 BD Biosciences
12.9.1 BD Biosciences Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Tumor Profiling Introduction
12.9.4 BD Biosciences Revenue in Cancer Tumor Profiling Business (2014-2019)
12.9.5 BD Biosciences Recent Development
12.10 Siemens Healthineers
12.10.1 Siemens Healthineers Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Tumor Profiling Introduction
12.10.4 Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2014-2019)
12.10.5 Siemens Healthineers Recent Development
12.11 Claris Life Sciences
12.12 Personal Genome Diagnostics, Inc.
12.13 Perthera, Inc.
12.14 Foundation Medicine, Inc
12.15 V., Strand
12.16 ApoCell
12.17 Contextual Genomics
12.18 Agendia
12.19 GenScript
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cancer Tumor Profiling Key Market Segments
Table Key Players Cancer Tumor Profiling Covered
Table Global Cancer Tumor Profiling Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cancer Tumor Profiling Market Size Market Share by Type 2014-2025
Figure Next-generation Sequencing (NGS) Figures
Table Key Players of Next-generation Sequencing (NGS)
Figure Polymerase Chain Reaction (PCR) Figures
Table Key Players of Polymerase Chain Reaction (PCR)
Figure Immunohistochemistry (IHC) Figures
Table Key Players of Immunohistochemistry (IHC)
Figure In Situ Hybridization (ISH) Figures
Table Key Players of In Situ Hybridization (ISH)
Figure Microarray Figures
Table Key Players of Microarray
Figure Others Figures
Table Key Players of Others
Table Global Cancer Tumor Profiling Market Size Growth by Application 2014-2025 (Million US$)
Figure Personalized Medicine Case Studies
Figure Diagnostics Case Studies
Figure Biomarker Discovery Case Studies
Figure Prognostics Case Studies
Figure Research Applications Case Studies
Figure Cancer Tumor Profiling Report Years Considered
Table Global Cancer Tumor Profiling Market Size 2014-2025 (Million US$)
Figure Global Cancer Tumor Profiling Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cancer Tumor Profiling Market Size by Regions 2014-2025 (Million US$)
Table Global Cancer Tumor Profiling Market Size by Regions 2014-2019 (Million US$)
Table Global Cancer Tumor Profiling Market Share by Regions 2014-2019
Figure Global Cancer Tumor Profiling Market Share by Regions 2014-2019
Figure Global Cancer Tumor Profiling Market Share by Regions 2019
Table Market Top Trends
Table Global Cancer Tumor Profiling Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cancer Tumor Profiling Market Share by Manufacturers (2014-2019)
Figure Global Cancer Tumor Profiling Market Share by Manufacturers in 2018
Table Global Cancer Tumor Profiling Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Tumor Profiling Product/Solution/Service
Table Date of Enter into Cancer Tumor Profiling Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$)
Table Global Cancer Tumor Profiling Market Size Share by Type (2014-2019)
Figure Global Cancer Tumor Profiling Market Size Market Share by Type (2014-2019)
Table Global Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$)
Table Global Cancer Tumor Profiling Market Size Share by Application (2014-2019)
Figure Global Cancer Tumor Profiling Market Size Market Share by Application (2014-2019)
Figure Global Cancer Tumor Profiling Revenue Market Share by Application in 2018
Figure United States Cancer Tumor Profiling Market Size 2014-2019 (Million US$)
Table United States Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$)
Table United States Key Players Cancer Tumor Profiling Market Share (2018-2019)
Table United States Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$)
Table United States Cancer Tumor Profiling Market Share by Type (2014-2019)
Table United States Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$)
Table United States Cancer Tumor Profiling Market Share by Application (2014-2019)
Figure Europe Cancer Tumor Profiling Market Size 2014-2019 (Million US$)
Table Europe Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$)
Table Europe Key Players Cancer Tumor Profiling Market Share (2018-2019)
Table Europe Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$)
Table Europe Cancer Tumor Profiling Market Share by Type (2014-2019)
Table Europe Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$)
Table Europe Cancer Tumor Profiling Market Share by Application (2014-2019)
Figure China Cancer Tumor Profiling Market Size 2014-2019 (Million US$)
Table China Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$)
Table China Key Players Cancer Tumor Profiling Market Share (2018-2019)
Table China Cancer Tumor Profiling Market Size by Type (2014-20189) (Million US$)
Table China Cancer Tumor Profiling Market Share by Type (2014-2019)
Table China Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$)
Table China Cancer Tumor Profiling Market Share by Application (2014-2019)
Figure Japan Cancer Tumor Profiling Market Size 2014-2019 (Million US$)
Table Japan Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$)
Table Japan Key Players Cancer Tumor Profiling Market Share (2018-2019)
Table Japan Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$)
Table Japan Cancer Tumor Profiling Market Share by Type (2014-2019)
Table Japan Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$)
Table Japan Cancer Tumor Profiling Market Share by Application (2014-2019)
Figure Southeast Asia Cancer Tumor Profiling Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cancer Tumor Profiling Market Share (2018-2019)
Table Southeast Asia Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cancer Tumor Profiling Market Share by Type (2014-2019)
Table Southeast Asia Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cancer Tumor Profiling Market Share by Application (2014-2019)
Figure India Cancer Tumor Profiling Market Size 2014-2019 (Million US$)
Table India Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$)
Table India Key Players Cancer Tumor Profiling Market Share (2018-2019)
Table India Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$)
Table India Cancer Tumor Profiling Market Share by Type (2014-2019)
Table India Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$)
Table India Cancer Tumor Profiling Market Share by Application (2014-2019)
Figure Central & South America Cancer Tumor Profiling Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cancer Tumor Profiling Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cancer Tumor Profiling Market Share (2018-2019)
Table Central & South America Cancer Tumor Profiling Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cancer Tumor Profiling Market Share by Type (2014-2019)
Table Central & South America Cancer Tumor Profiling Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cancer Tumor Profiling Market Share by Application (2014-2019)
Table Qiagen N.V. Company Details
Table Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2014-2019) (Million US$)
Figure Qiagen N.V. Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019)
Table Qiagen N.V. Recent Development
Table Roche Molecular Systems Inc. Company Details
Table Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$)
Figure Roche Molecular Systems Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019)
Table Roche Molecular Systems Inc. Recent Development
Table Abott Molecular Company Details
Table Abott Molecular Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$)
Figure Abott Molecular Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019)
Table Abott Molecular Recent Development
Table Illumina Inc. Company Details
Table Illumina Inc. Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$)
Figure Illumina Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019)
Table Illumina Inc. Recent Development
Table NeoGenomics Laboratories Company Details
Table NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$)
Figure NeoGenomics Laboratories Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019)
Table NeoGenomics Laboratories Recent Development
Table HTG Molecular Diagnostic Company Details
Table HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$)
Figure HTG Molecular Diagnostic Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019)
Table HTG Molecular Diagnostic Recent Development
Table Genomic Health Inc. Company Details
Table Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$)
Figure Genomic Health Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019)
Table Genomic Health Inc. Recent Development
Table Hologic Gen-Probe Company Details
Table Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$)
Figure Hologic Gen-Probe Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019)
Table Hologic Gen-Probe Recent Development
Table BD Biosciences Company Details
Table BD Biosciences Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$)
Figure BD Biosciences Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019)
Table BD Biosciences Recent Development
Table Siemens Healthineers Company Details
Table Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2014-2019)(Million US$)
Figure Siemens Healthineers Revenue Growth Rate in Cancer Tumor Profiling Business (2014-2019)
Table Siemens Healthineers Recent Development
Table Claris Life Sciences Company Details
Table Personal Genome Diagnostics, Inc. Company Details
Table Perthera, Inc. Company Details
Table Foundation Medicine, Inc Company Details
Table V., Strand Company Details
Table ApoCell Company Details
Table Contextual Genomics Company Details
Table Agendia Company Details
Table GenScript Company Details
Table Global Cancer Tumor Profiling Market Size by Regions (Million US$) 2019-2025
Figure Global Cancer Tumor Profiling Market Size Share by Regions (2019-2025)
Figure Global Cancer Tumor Profiling Market Size Share by Regions in 2025
Figure United States Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD)
Figure China Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD)
Figure India Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cancer Tumor Profiling Market Size Forecast (2019-2025)(Million USD)
Table Global Cancer Tumor Profiling Market Size by Product (2019-2025) (Million US$)
Figure Global Cancer Tumor Profiling Market Size by Product (2019-2025)
Figure Global Cancer Tumor Profiling Market Size by Product in 2025
Table Global Cancer Tumor Profiling Market Size by Application (2019-2025) (Million US$)
Figure Global Cancer Tumor Profiling Market Size by Application (2019-2025)
Figure Global Cancer Tumor Profiling Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
外科的腫瘍アブレーションの世界市場：市場規模・現状・予測 Surgical Tumor Ablation is a minimally invasive technique that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung. It is an important option for people who have failed chemotherapy or radiotherapy or are not surgical candidates. In 2018, the global Surgical Tumor Ablati…- 外科的腫瘍アブレーションの世界市場：市場規模・現状・予測 Surgical Tumor Ablation is a minimally invasive technique that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung. It is an important option for people who have failed chemotherapy or radiotherapy or are not surgical candidates. In 2018, the global Surgical Tumor Ablati…
- 循環腫瘍細胞（CTC）予後技術の世界市場：市場規模・現状・予測 Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
- 固形腫瘍治療法の世界市場：市場規模・現状・予測 In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst.Increasing incidences of solid tumor among cancer patients and growing prevalence of various types of metastatic cancers are the major factors that are expected to drive the growth of the…
- 固形腫瘍治療法の世界市場：市場規模・現状・予測 In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst.Increasing incidences of solid tumor among cancer patients and growing prevalence of various types of metastatic cancers are the major factors that are expected to drive the growth of the…